Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers

Baker, 2004, Addiction motivation reformulated: an affective processing model of negative reinforcement, Psychol. Rev., 111, 33, 10.1037/0033-295X.111.1.33

Bigos, 2008, Acute 5-HT reuptake blockade potentiates human amygdala reactivity, Neuropsychopharmacology, 33, 3221, 10.1038/npp.2008.52

Chase, 2011, The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis, Biol. Psychiatry, 70, 785, 10.1016/j.biopsych.2011.05.025

Cox, 1996, AFNI: software for analysis and visualization of functional magnetic resonance neuroimages, Comput. Biomed. Res., 29, 162, 10.1006/cbmr.1996.0014

Evatt, 2010, Smoking, arousal, and affect: the role of anxiety sensitivity, J. Anxiety Disord., 24, 114, 10.1016/j.janxdis.2009.09.006

Faessel, 2006, Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers, J. Clin. Pharmacol., 46, 1439, 10.1177/0091270006292624

Franklin, 2011, Effects of varenicline on smoking cue-triggered neural and craving responses, Arch. Gen. Psychiatry, 68, 516, 10.1001/archgenpsychiatry.2010.190

Franklin, 2011, Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort, Addict. Biol., 16, 308, 10.1111/j.1369-1600.2010.00277.x

Gonzales, 2006, Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation — a randomized controlled trial, JAMA, 296, 47, 10.1001/jama.296.1.47

Greenwood, 2012, A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4, Neurosci. Biobehav. Rev., 36, 1331, 10.1016/j.neubiorev.2012.02.010

Hariri, 2002, Serotonin transporter genetic variation and the response of the human amygdala, Science, 297, 400, 10.1126/science.1071829

Hariri, 2002, The amygdala response to emotional stimuli: a comparison of faces and scenes, Neuroimage, 17, 317, 10.1006/nimg.2002.1179

Heatherton, 1991, The fagerstrom test for nicotine dependence — a revision of the Fagerstrom Tolerance Questionnaire, Br. J. Addict., 86, 1119, 10.1111/j.1360-0443.1991.tb01879.x

Heishman, 1994, Nicotine and smoking: a review of effects on human performance, Exp. Clin. Psychopharmacol., 2, 345, 10.1037/1064-1297.2.4.345

Hughes, 2007, Effects of abstinence from tobacco: valid symptoms and time course, Nicotine Tob. Res., 9, 315, 10.1080/14622200701188919

Janes, 2010, Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence, Biol. Psychiatry, 67, 722, 10.1016/j.biopsych.2009.12.034

Jasinska, 2012, Amygdala response to smoking-cessation messages mediates the effects of serotonin transporter gene variation on quitting, Neuroimage, 60, 766, 10.1016/j.neuroimage.2011.12.064

Jorenby, 2006, Efficacy of varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation — a randomized controlled trial, JAMA, 296, 56, 10.1001/jama.296.1.56

Kassel, 2003, Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking, Psychol. Bull., 129, 270, 10.1037/0033-2909.129.2.270

Kleykamp, 2011, Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers, Exp. Clin. Psychopharmacol., 19, 75, 10.1037/a0022417

Koob, 2009, Brain stress systems in the amygdala and addiction, Brain Res., 1293, 61, 10.1016/j.brainres.2009.03.038

Koob, 2005, Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction, Nat. Neurosci., 8, 1442, 10.1038/nn1105-1442

Kriegeskorte, 2009, Circular analysis in systems neuroscience: the dangers of double dipping, Nat. Neurosci., 12, 535, 10.1038/nn.2303

Kuhn, 2011, Common biology of craving across legal and illegal drugs — a quantitative meta-analysis of cue-reactivity brain response, Eur. J. Neurosci., 33, 1318, 10.1111/j.1460-9568.2010.07590.x

Kukolja, 2008, Modeling a negative response bias in the human amygdala by noradrenergic-glucocorticoid interactions, J. Neurosci., 28, 12868, 10.1523/JNEUROSCI.3592-08.2008

Labuschagne, 2010, Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder, Neuropsychopharmacology, 35, 2403, 10.1038/npp.2010.123

Lee, 2011, Effects of 24 hours of tobacco withdrawal and subsequent tobacco smoking among low and high sensation seekers, Nicotine Tob. Res., 13, 943, 10.1093/ntr/ntr102

Li, 2010, Cytisine induces autonomic cardiovascular responses via activations of different nicotinic receptors, Auton. Neurosci., 154, 14, 10.1016/j.autneu.2009.09.023

Loughead, 2009, Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype, Mol. Psychiatry, 14, 820, 10.1038/mp.2008.132

Loughead, 2010, Effects of the alpha 4 beta 2 partial agonist varenicline on brain activity and working memory in abstinent smokers, Biol. Psychol., 67, 715, 10.1016/j.biopsych.2010.01.016

Loughead, 2011, Brain activity and emotional processing in smokers treated with varenicline, Addict. Biol.

Mihalak, 2006, Varenicline is a partial agonist at alpha 4 beta 2 and a full agonist at alpha 7 neuronal nicotinic receptors, Mol. Pharmacol., 70, 801, 10.1124/mol.106.025130

Mihov, 2012, Altered amygdala function in nicotine addiction: insights from human neuroimaging studies, Neuropsychologia, 50, 1719, 10.1016/j.neuropsychologia.2012.04.028

Myers, 2008, Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray, Neuropsychopharmacology, 33, 588, 10.1038/sj.npp.1301425

Newhouse, 2004, Effects of nicotinic stimulation on cognitive performance, Curr. Opin. Pharmacol., 4, 36, 10.1016/j.coph.2003.11.001

Palmer, 1992, Transdermal nicotine — a review of Its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation, Drugs, 44, 498, 10.2165/00003495-199244030-00011

Patterson, 2009, Varenicline improves mood and cognition during smoking abstinence, Biol. Psychol., 65, 144, 10.1016/j.biopsych.2008.08.028

Patterson, 2010, Working memory deficits predict short-term smoking resumption following brief abstinence, Drug Alcohol Depend., 106, 61, 10.1016/j.drugalcdep.2009.07.020

Paulus, 2005, Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing, Arch. Gen. Psychiatry, 62, 282, 10.1001/archpsyc.62.3.282

Phelps, 2005, Contributions of the amygdala to emotion processing: from animal models to human behavior, Neuron, 48, 175, 10.1016/j.neuron.2005.09.025

Piasecki, 2006, Relapse to smoking, Clin. Psychol. Rev., 26, 196, 10.1016/j.cpr.2005.11.007

Piper, 2011, Tobacco withdrawal components and their relations with cessation success, Psychopharmacology (Berl), 216, 569, 10.1007/s00213-011-2250-3

Pourtois, 2010, Errors recruit both cognitive and emotional monitoring systems: Simultaneous intracranial recordings in the dorsal anterior cingulate gyrus and amygdala combined with fMRI, Neuropsychologia, 48, 1144, 10.1016/j.neuropsychologia.2009.12.020

Rollema, 2007, Rationale, pharmacology and clinical efficacy of partial agonists of alpha(4)beta(2) nACh receptors for smoking cessation, Trends Pharmacol. Sci., 28, 316, 10.1016/j.tips.2007.05.003

Rollema, 2009, Preclinical pharmacology of the alpha 4 beta 2 nAChR partial agonist varenicline related to effects on reward, mood and cognition, Biochem. Pharmacol., 78, 813, 10.1016/j.bcp.2009.05.033

Rose, 2003, PET studies of the influences of nicotine on neural systems in cigarette smokers, Am. J. Psychiatry, 160, 323, 10.1176/appi.ajp.160.2.323

Rose, 2007, Regional brain activity correlates of nicotine dependence, Neuropsychopharmacology, 32, 2441, 10.1038/sj.npp.1301379

Rukstalis, 2005, Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy, J. Subst. Abuse Treat., 28, 297, 10.1016/j.jsat.2005.02.002

Sergerie, 2008, The role of the amygdala in emotional processing: a quantitative meta-analysis of functional neuroimaging studies, Neurosci. Biobehav. Rev., 32, 811, 10.1016/j.neubiorev.2007.12.002

Smolka, 2006, Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery, Psychopharmacology (Berl), 184, 577, 10.1007/s00213-005-0080-x

Sofuoglu, 2009, Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans, Psychopharmacology (Berl), 207, 153, 10.1007/s00213-009-1643-z

SRNT-Subcommittee, 2002, Biochemical verification of tobacco use and cessation, Nicotine Tob. Res., 4, 149, 10.1080/14622200210123581

van Marle, 2011, Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals, Neuroimage, 55, 825, 10.1016/j.neuroimage.2010.12.051

Wang, 2007, Neural substrates of abstinence-induced cigarette cravings in chronic smokers, J. Neurosci., 27, 14035, 10.1523/JNEUROSCI.2966-07.2007

Winterer, 2010, Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance, Am. J. Med. Genet. B Neuropsychiatr. Genet., 153B, 1448, 10.1002/ajmg.b.31126

Wise, 2008, Cocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine release, PLoS One, 3, e2846, 10.1371/journal.pone.0002846

Zubieta, 2005, Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence, Am. J. Psychiatry, 162, 567, 10.1176/appi.ajp.162.3.567